| Financial Year |
March 31 2023 |
| Monetary Funds |
7,107,436.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
578,608,511.37 |
| Advances to Suppliers |
-- |
| Other Receivables |
26,204,502.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,685,312.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,429,711.23 |
| Total Current Assets |
1,718,544,740.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,705,518.11 |
| Long-term Equity Investment |
9,179,413.00 |
| Investment Properties |
-- |
| Fixed Assetes |
88,388,405.47 |
| Under-construction Projects |
52,847.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
6,718,970.87 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,399,588.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
166,638,845.34 |
| Other Non-Current Assets |
2,005,345,699.65 |
| Sub-Total of Non-Current Assets |
2,342,429,287.50 |
| Total Assets |
4,060,974,027.88 |
| Short-Term Loans |
1,217,281,604.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
869,588,456.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,641,686.25 |
| Taxes Payable |
30,756,778.20 |
| Interest Payable |
222,050,868.83 |
| Dividend Payable |
-- |
| Other payables |
362,560,410.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,100,872.49 |
| Other Current Liabilities |
157,014,443.15 |
| Sub-Total of Current Liabilities |
2,726,944,252.43 |
| Long-term Loans |
170,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
542,778,494.56 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
712,778,494.56 |
| Total Liabilities |
3,439,722,746.99 |
| Paid-In Capital(Or Share Stock) |
674,279,488.00 |
| Capital Surplus |
2,345,054,968.46 |
| Surplus Reserve |
53,903,805.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,465,785,866.45 |
| Minority Stockholder's Interest |
17,976,939.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
603,274,341.66 |
| Owner's Equity（Stockholder's Equity） |
621,251,280.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,060,974,027.88 |
